| Symbol |
Name |
|
A2MP1
|
alpha-2-macroglobulin pseudogene 1
|
|
AAAS
|
achalasia, adrenocortical insufficiency, alacrimia
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)
|
|
ABCB9
|
ATP-binding cassette, sub-family B (MDR/TAP), member 9
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCC5
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 5
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ACADVL
|
acyl-CoA dehydrogenase, very long chain
|
|
ACAN
|
aggrecan
|
|
ACAT1
|
acetyl-CoA acetyltransferase 1
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACLY
|
ATP citrate lyase
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
|
ACTG1
|
actin gamma 1
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ACTN4
|
actinin, alpha 4
|
|
ACVR2A
|
activin A receptor, type IIA
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADA
|
adenosine deaminase
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM28
|
ADAM metallopeptidase domain 28
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
|
ADAMTS9
|
ADAM metallopeptidase with thrombospondin type 1 motif, 9
|
|
ADCY2
|
adenylate cyclase 2 (brain)
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
ADGRG1
|
adhesion G protein-coupled receptor G1
|
|
ADHFE1
|
alcohol dehydrogenase, iron containing, 1
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRA1B
|
adrenoceptor alpha 1B
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ADSL
|
adenylosuccinate lyase
|
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGL
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGPAT3
|
1-acylglycerol-3-phosphate O-acyltransferase 3
|
|
AGR3
|
anterior gradient 3
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHI1
|
Abelson helper integration site 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AIMP2
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AIPL1
|
aryl hydrocarbon receptor interacting protein-like 1
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALB
|
albumin
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2
|
|
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1
|
|
ALDH3A2
|
aldehyde dehydrogenase 3 family, member A2
|
|
ALDH5A1
|
aldehyde dehydrogenase 5 family, member A1
|
|
ALDH6A1
|
aldehyde dehydrogenase 6 family, member A1
|
|
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALKBH8
|
alkB, alkylation repair homolog 8 (E. coli)
|
|
ALMS1
|
Alstrom syndrome protein 1
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ALS2
|
amyotrophic lateral sclerosis 2 (juvenile)
|
|
AMBP
|
alpha-1-microglobulin/bikunin precursor
|
|
AMELX
|
amelogenin, X-linked
|
|
AMN
|
amnion associated transmembrane protein
|
|
AMPD1
|
adenosine monophosphate deaminase 1
|
|
ANAPC7
|
anaphase promoting complex subunit 7
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL3
|
angiopoietin-like 3
|
|
ANK1
|
ankyrin 1, erythrocytic
|
|
ANKH
|
ANKH inorganic pyrophosphate transport regulator
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANKRD1
|
ankyrin repeat domain 1 (cardiac muscle)
|
|
ANKRD30A
|
ankyrin repeat domain 30A
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANO2
|
anoctamin 2, calcium activated chloride channel
|
|
ANO5
|
anoctamin 5
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
ANXA3
|
annexin A3
|
|
ANXA5
|
annexin A5
|
|
ANXA7
|
annexin A7
|
|
AP3M1
|
adaptor-related protein complex 3, mu 1 subunit
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APLF
|
aprataxin and PNKP like factor
|
|
APLN
|
apelin
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA2
|
apolipoprotein A-II
|
|
APOA4
|
apolipoprotein A-IV
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APOL1
|
apolipoprotein L, 1
|
|
APOM
|
apolipoprotein M
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AQP4
|
aquaporin 4
|
|
AQP9
|
aquaporin 9
|
|
AR
|
androgen receptor
|
|
ARF1
|
ADP-ribosylation factor 1
|
|
ARFGEF1
|
ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)
|
|
ARG1
|
arginase 1
|
|
ARG2
|
arginase 2
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARL2
|
ADP-ribosylation factor-like 2
|
|
ARL6
|
ADP-ribosylation factor-like 6
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARRB2
|
arrestin, beta 2
|
|
ARSG
|
arylsulfatase G
|
|
AS3MT
|
arsenite methyltransferase
|
|
ASAH2
|
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2
|
|
ASB9
|
ankyrin repeat and SOCS box containing 9
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASGR1
|
asialoglycoprotein receptor 1
|
|
ASGR2
|
asialoglycoprotein receptor 2
|
|
ASIP
|
agouti signaling protein
|
|
ASL
|
argininosuccinate lyase
|
|
ASPNAT
|
aspartate N-acetyltransferase
|
|
ASS1
|
argininosuccinate synthase 1
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATF4
|
activating transcription factor 4
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATG4A
|
autophagy related 4A, cysteine peptidase
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP11B
|
ATPase, class VI, type 11B
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
|
ATP13A2
|
ATPase type 13A2
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
|
ATP2B3
|
ATPase, Ca++ transporting, plasma membrane 3
|
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1
|
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
|
|
ATP6V0A2
|
ATPase, H+ transporting, lysosomal V0 subunit a2
|
|
ATP6V0A4
|
ATPase, H+ transporting, lysosomal V0 subunit a4
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
ATXN2
|
ataxin 2
|
|
ATXN3
|
ataxin 3
|
|
ATXN7
|
ataxin 7
|
|
ATXN8OS
|
ATXN8 opposite strand (non-protein coding)
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AVP
|
arginine vasopressin
|
|
AXIN2
|
axin 2
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
B3GALTL
|
beta 1,3-galactosyltransferase-like
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
BAAT
|
bile acid CoA:amino acid N-acyltransferase
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BACH1
|
BTB and CNC homology 1, basic leucine zipper transcription factor 1
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAG6
|
BCL2-associated athanogene 6
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAMBI
|
BMP and activin membrane-bound inhibitor
|
|
BAX
|
BCL2-associated X protein
|
|
BBS10
|
Bardet-Biedl syndrome 10
|
|
BBS2
|
Bardet-Biedl syndrome 2
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BCS1L
|
BC1 (ubiquinol-cytochrome c reductase) synthesis-like
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BEST1
|
bestrophin 1
|
|
BFSP2
|
beaded filament structural protein 2, phakinin
|
|
BIN1
|
bridging integrator 1
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLMH
|
bleomycin hydrolase
|
|
BLNK
|
B-cell linker
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BPI
|
bactericidal/permeability-increasing protein
|
|
BPIFA1
|
BPI fold containing family A, member 1
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRAP
|
BRCA1 associated protein
|
|
BRAT1
|
BRCA1-associated ATM activator 1
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRD2
|
bromodomain containing 2
|
|
BRD7
|
bromodomain containing 7
|
|
BSG
|
basigin (Ok blood group)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
BVES
|
blood vessel epicardial substance
|
|
C10ORF2
|
chromosome 10 open reading frame 2
|
|
C1GALT1
|
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
C1QTNF5
|
C1q and tumor necrosis factor related protein 5
|
|
C2
|
complement component 2
|
|
C3
|
complement component 3
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
C4BPA
|
complement component 4 binding protein, alpha
|
|
C5AR2
|
complement component 5a receptor 2
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CA9
|
carbonic anhydrase IX
|
|
CABP1
|
calcium binding protein 1
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1F
|
calcium channel, voltage-dependent, L type, alpha 1F subunit
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1
|
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit
|
|
CACNB4
|
calcium channel, voltage-dependent, beta 4 subunit
|
|
CADM1
|
cell adhesion molecule 1
|
|
CAGE1
|
cancer antigen 1
|
|
CALHM1
|
calcium homeostasis modulator 1
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CALR
|
calreticulin
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAMTA1
|
calmodulin binding transcription activator 1
|
|
CAPG
|
capping protein (actin filament), gelsolin-like
|
|
CAPN10
|
calpain 10
|
|
CAPN3
|
calpain 3, (p94)
|
|
CAPRIN1
|
cell cycle associated protein 1
|
|
CAPZA1
|
capping protein (actin filament) muscle Z-line, alpha 1
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CASC5
|
cancer susceptibility candidate 5
|
|
CASP14
|
caspase 14, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP5
|
caspase 5, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CAV3
|
caveolin 3
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CBX1
|
chromobox homolog 1
|
|
CBX3
|
chromobox homolog 3
|
|
CBX5
|
chromobox homolog 5
|
|
CC2D1A
|
coiled-coil and C2 domain containing 1A
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCL4L1
|
chemokine (C-C motif) ligand 4-like 1
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCNC
|
cyclin C
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCNDBP1
|
cyclin D-type binding-protein 1
|
|
CCNE1
|
cyclin E1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR4
|
chemokine (C-C motif) receptor 4
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CCR8
|
chemokine (C-C motif) receptor 8
|
|
CCS
|
copper chaperone for superoxide dismutase
|
|
CD14
|
CD14 molecule
|
|
CD163
|
CD163 molecule
|
|
CD19
|
CD19 molecule
|
|
CD1A
|
CD1a molecule
|
|
CD1C
|
CD1c molecule
|
|
CD1D
|
CD1d molecule
|
|
CD2
|
CD2 molecule
|
|
CD200
|
CD200 molecule
|
|
CD209
|
CD209 molecule
|
|
CD24
|
CD24 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD47
|
CD47 molecule
|
|
CD5
|
CD5 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD68
|
CD68 molecule
|
|
CD7
|
CD7 molecule
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
|
CD81
|
CD81 molecule
|
|
CD82
|
CD82 molecule
|
|
CD86
|
CD86 molecule
|
|
CD8A
|
CD8a molecule
|
|
CD9
|
CD9 molecule
|
|
CD96
|
CD96 molecule
|
|
CD99
|
CD99 molecule
|
|
CDC27
|
cell division cycle 27
|
|
CDC37
|
cell division cycle 37
|
|
CDC45
|
cell division cycle 45
|
|
CDC73
|
cell division cycle 73
|
|
CDCP1
|
CUB domain containing protein 1
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKL5
|
cyclin-dependent kinase-like 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CENPA
|
centromere protein A
|
|
CERS3
|
ceramide synthase 3
|
|
CES2
|
carboxylesterase 2
|
|
CETN2
|
centrin, EF-hand protein, 2
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFB
|
complement factor B
|
|
CFH
|
complement factor H
|
|
CFHR1
|
complement factor H-related 1
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CGB5
|
chorionic gonadotropin, beta polypeptide 5
|
|
CGGBP1
|
CGG triplet repeat binding protein 1
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHD1L
|
chromodomain helicase DNA binding protein 1-like
|
|
CHD6
|
chromodomain helicase DNA binding protein 6
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHGB
|
chromogranin B
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHL1
|
cell adhesion molecule L1-like
|
|
CHPF
|
chondroitin polymerizing factor
|
|
CHPF2
|
chondroitin polymerizing factor 2
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNA6
|
cholinergic receptor, nicotinic, alpha 6 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHST6
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6
|
|
CHSY1
|
chondroitin sulfate synthase 1
|
|
CHSY3
|
chondroitin sulfate synthase 3
|
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
|
CIC
|
capicua transcriptional repressor
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CLDN1
|
claudin 1
|
|
CLDN16
|
claudin 16
|
|
CLDN4
|
claudin 4
|
|
CLDN5
|
claudin 5
|
|
CLDN7
|
claudin 7
|
|
CLEC12A
|
C-type lectin domain family 12, member A
|
|
CLEC4M
|
C-type lectin domain family 4, member M
|
|
CLIC1
|
chloride intracellular channel 1
|
|
CLIC4
|
chloride intracellular channel 4
|
|
CLN3
|
ceroid-lipofuscinosis, neuronal 3
|
|
CLN6
|
ceroid-lipofuscinosis, neuronal 6, late infantile, variant
|
|
CLOCK
|
clock circadian regulator
|
|
CLU
|
clusterin
|
|
CMA1
|
chymase 1, mast cell
|
|
CNBP
|
CCHC-type zinc finger, nucleic acid binding protein
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTF
|
ciliary neurotrophic factor
|
|
COCH
|
cochlin
|
|
COL11A1
|
collagen, type XI, alpha 1
|
|
COL11A2
|
collagen, type XI, alpha 2
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL22A1
|
collagen, type XXII, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A2
|
collagen, type IV, alpha 2
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL6A1
|
collagen, type VI, alpha 1
|
|
COL6A3
|
collagen, type VI, alpha 3
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
COL8A2
|
collagen, type VIII, alpha 2
|
|
COMT
|
catechol-O-methyltransferase
|
|
COTL1
|
coactosin-like F-actin binding protein 1
|
|
COX18
|
COX18 cytochrome c oxidase assembly factor
|
|
COX19
|
COX19 cytochrome c oxidase assembly factor
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1
|
|
CPN1
|
carboxypeptidase N, polypeptide 1
|
|
CPS1
|
carbamoyl-phosphate synthase 1, mitochondrial
|
|
CPSF1
|
cleavage and polyadenylation specific factor 1, 160kDa
|
|
CPSF3L
|
cleavage and polyadenylation specific factor 3-like
|
|
CPT1B
|
carnitine palmitoyltransferase 1B (muscle)
|
|
CPT2
|
carnitine palmitoyltransferase 2
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CRADD
|
CASP2 and RIPK1 domain containing adaptor with death domain
|
|
CRB2
|
crumbs family member 2
|
|
CRBN
|
cereblon
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CREM
|
cAMP responsive element modulator
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CRISPLD2
|
cysteine-rich secretory protein LCCL domain containing 2
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CRYAA
|
crystallin, alpha A
|
|
CRYBB2
|
crystallin, beta B2
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSH1
|
chorionic somatomammotropin hormone 1 (placental lactogen)
|
|
CSK
|
c-src tyrosine kinase
|
|
CSMD1
|
CUB and Sushi multiple domains 1
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CSPG5
|
chondroitin sulfate proteoglycan 5 (neuroglycan C)
|
|
CST3
|
cystatin C
|
|
CST8
|
cystatin 8 (cystatin-related epididymal specific)
|
|
CSTB
|
cystatin B (stefin B)
|
|
CT45A1
|
cancer/testis antigen family 45, member A1
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTH
|
cystathionine gamma-lyase
|
|
CTHRC1
|
collagen triple helix repeat containing 1
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNS
|
cystinosin, lysosomal cystine transporter
|
|
CTSB
|
cathepsin B
|
|
CTSC
|
cathepsin C
|
|
CTSL
|
cathepsin L
|
|
CTSS
|
cathepsin S
|
|
CTSW
|
cathepsin W
|
|
CTTN
|
cortactin
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CYB5A
|
cytochrome b5 type A (microsomal)
|
|
CYB5R3
|
cytochrome b5 reductase 3
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYBRD1
|
cytochrome b reductase 1
|
|
CYGB
|
cytoglobin
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A1P
|
cytochrome P450, family 21, subfamily A, polypeptide 1 pseudogene
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
CYP2A13
|
cytochrome P450, family 2, subfamily A, polypeptide 13
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
|
CYP7A1
|
cytochrome P450, family 7, subfamily A, polypeptide 1
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
CYTH2
|
cytohesin 2
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DAB2IP
|
DAB2 interacting protein
|
|
DAO
|
D-amino-acid oxidase
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAZL
|
deleted in azoospermia-like
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DCAF17
|
DDB1 and CUL4 associated factor 17
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCD
|
dermcidin
|
|
DCN
|
decorin
|
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DDX11
|
DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEK
|
DEK proto-oncogene
|
|
DES
|
desmin
|
|
DHCR7
|
7-dehydrocholesterol reductase
|
|
DHFR
|
dihydrofolate reductase
|
|
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DIAPH1
|
diaphanous-related formin 1
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DIRAS3
|
DIRAS family, GTP-binding RAS-like 3
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DLL3
|
delta-like 3 (Drosophila)
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DMD
|
dystrophin
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOCK8
|
dedicator of cytokinesis 8
|
|
DPP9
|
dipeptidyl-peptidase 9
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DPYSL5
|
dihydropyrimidinase-like 5
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DSG1
|
desmoglein 1
|
|
DSG3
|
desmoglein 3
|
|
DST
|
dystonin
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DTX3L
|
deltex 3 like, E3 ubiquitin ligase
|
|
DUOX1
|
dual oxidase 1
|
|
DUOX2
|
dual oxidase 2
|
|
DUX4L1
|
double homeobox 4 like 1
|
|
DYNLL1
|
dynein, light chain, LC8-type 1
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
DYSF
|
dysferlin
|
|
E2F1
|
E2F transcription factor 1
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EDA
|
ectodysplasin A
|
|
EDN1
|
endothelin 1
|
|
EDN3
|
endothelin 3
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EED
|
embryonic ectoderm development
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EFNA1
|
ephrin-A1
|
|
EFNB2
|
ephrin-B2
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGR1
|
early growth response 1
|
|
EHD3
|
EH-domain containing 3
|
|
EID1
|
EP300 interacting inhibitor of differentiation 1
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
ELAC2
|
elaC ribonuclease Z 2
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ELMO1
|
engulfment and cell motility 1
|
|
ELMO3
|
engulfment and cell motility 3
|
|
ELN
|
elastin
|
|
ELOVL4
|
ELOVL fatty acid elongase 4
|
|
EMILIN1
|
elastin microfibril interfacer 1
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
|
ENG
|
endoglin
|
|
ENGASE
|
endo-beta-N-acetylglucosaminidase
|
|
ENO1
|
enolase 1, (alpha)
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
ENTPD4
|
ectonucleoside triphosphate diphosphohydrolase 4
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPB41
|
erythrocyte membrane protein band 4.1
|
|
EPB41L4A-AS1
|
EPB41L4A antisense RNA 1
|
|
EPB41L4B
|
erythrocyte membrane protein band 4.1 like 4B
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA1
|
EPH receptor A1
|
|
EPHA2
|
EPH receptor A2
|
|
EPHA4
|
EPH receptor A4
|
|
EPHB2
|
EPH receptor B2
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
EPS15
|
epidermal growth factor receptor pathway substrate 15
|
|
EPS8
|
epidermal growth factor receptor pathway substrate 8
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERO1LB
|
ERO1-like beta (S. cerevisiae)
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV1
|
ets variant 1
|
|
ETV6
|
ets variant 6
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EXOC2
|
exocyst complex component 2
|
|
EXOC8
|
exocyst complex component 8
|
|
EXOSC3
|
exosome component 3
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F10
|
coagulation factor X
|
|
F11
|
coagulation factor XI
|
|
F11R
|
F11 receptor
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F13B
|
coagulation factor XIII, B polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FABP1
|
fatty acid binding protein 1, liver
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAM20A
|
family with sequence similarity 20, member A
|
|
FAM3A
|
family with sequence similarity 3, member A
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBL
|
fibrillarin
|
|
FBLIM1
|
filamin binding LIM protein 1
|
|
FBLN1
|
fibulin 1
|
|
FBLN2
|
fibulin 2
|
|
FBN1
|
fibrillin 1
|
|
FBP1
|
fructose-1,6-bisphosphatase 1
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FBXW8
|
F-box and WD repeat domain containing 8
|
|
FCAR
|
Fc fragment of IgA receptor
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FDX1
|
ferredoxin 1
|
|
FECH
|
ferrochelatase
|
|
FFAR4
|
free fatty acid receptor 4
|
|
FGA
|
fibrinogen alpha chain
|
|
FGB
|
fibrinogen beta chain
|
|
FGD2
|
FYVE, RhoGEF and PH domain containing 2
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF14
|
fibroblast growth factor 14
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGG
|
fibrinogen gamma chain
|
|
FH
|
fumarate hydratase
|
|
FHIT
|
fragile histidine triad
|
|
FHL1
|
four and a half LIM domains 1
|
|
FHL2
|
four and a half LIM domains 2
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FIZ1
|
FLT3-interacting zinc finger 1
|
|
FKBP1A
|
FK506 binding protein 1A, 12kDa
|
|
FKBP1B
|
FK506 binding protein 1B, 12.6 kDa
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLG
|
filaggrin
|
|
FLII
|
flightless I homolog (Drosophila)
|
|
FLNA
|
filamin A, alpha
|
|
FLNC
|
filamin C, gamma
|
|
FLOT2
|
flotillin 2
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FLVCR1
|
feline leukemia virus subgroup C cellular receptor 1
|
|
FMO3
|
flavin containing monooxygenase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOLR2
|
folate receptor 2 (fetal)
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSL2
|
FOS-like antigen 2
|
|
FOXA1
|
forkhead box A1
|
|
FOXC1
|
forkhead box C1
|
|
FOXE1
|
forkhead box E1
|
|
FOXI1
|
forkhead box I1
|
|
FOXL2
|
forkhead box L2
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP1
|
forkhead box P1
|
|
FOXP3
|
forkhead box P3
|
|
FPR1
|
formyl peptide receptor 1
|
|
FPR2
|
formyl peptide receptor 2
|
|
FREM2
|
FRAS1 related extracellular matrix protein 2
|
|
FRG2
|
FSHD region gene 2
|
|
FRZB
|
frizzled-related protein
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FST
|
follistatin
|
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein)
|
|
FTH1
|
ferritin, heavy polypeptide 1
|
|
FTMT
|
ferritin mitochondrial
|
|
FTO
|
fat mass and obesity associated
|
|
FUS
|
FUS RNA binding protein
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FZD6
|
frizzled class receptor 6
|
|
G6PC3
|
glucose 6 phosphatase, catalytic, 3
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAA
|
glucosidase, alpha; acid
|
|
GABARAP
|
GABA(A) receptor-associated protein
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
|
GABBR2
|
gamma-aminobutyric acid (GABA) B receptor, 2
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GABRG1
|
gamma-aminobutyric acid (GABA) A receptor, gamma 1
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GABRG3
|
gamma-aminobutyric acid (GABA) A receptor, gamma 3
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GALNS
|
galactosamine (N-acetyl)-6-sulfatase
|
|
GALNT1
|
polypeptide N-acetylgalactosaminyltransferase 1
|
|
GALNT3
|
polypeptide N-acetylgalactosaminyltransferase 3
|
|
GALT
|
galactose-1-phosphate uridylyltransferase
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GAPDHS
|
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic
|
|
GARS
|
glycyl-tRNA synthetase
|
|
GAS1
|
growth arrest-specific 1
|
|
GAS6
|
growth arrest-specific 6
|
|
GAST
|
gastrin
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GATA5
|
GATA binding protein 5
|
|
GBA
|
glucosidase, beta, acid
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
|
GBP2
|
guanylate binding protein 2, interferon-inducible
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCG
|
glucagon
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCLC
|
glutamate-cysteine ligase, catalytic subunit
|
|
GCLM
|
glutamate-cysteine ligase, modifier subunit
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF3
|
growth differentiation factor 3
|
|
GDF5
|
growth differentiation factor 5
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GFRA1
|
GDNF family receptor alpha 1
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRH
|
growth hormone releasing hormone
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA3
|
gap junction protein, alpha 3, 46kDa
|
|
GJA8
|
gap junction protein, alpha 8, 50kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJD2
|
gap junction protein, delta 2, 36kDa
|
|
GLA
|
galactosidase, alpha
|
|
GLB1
|
galactosidase, beta 1
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLIS3
|
GLIS family zinc finger 3
|
|
GLMN
|
glomulin, FKBP associated protein
|
|
GLO1
|
glyoxalase I
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GLRA3
|
glycine receptor, alpha 3
|
|
GLRX2
|
glutaredoxin 2
|
|
GLRX3
|
glutaredoxin 3
|
|
GLS2
|
glutaminase 2 (liver, mitochondrial)
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GNAI3
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3
|
|
GNAO1
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNB1L
|
guanine nucleotide binding protein (G protein), beta polypeptide 1-like
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNB4
|
guanine nucleotide binding protein (G protein), beta polypeptide 4
|
|
GNLY
|
granulysin
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GOLGA2
|
golgin A2
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPBAR1
|
G protein-coupled bile acid receptor 1
|
|
GPC3
|
glypican 3
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPI
|
glucose-6-phosphate isomerase
|
|
GPR143
|
G protein-coupled receptor 143
|
|
GPR17
|
G protein-coupled receptor 17
|
|
GPR34
|
G protein-coupled receptor 34
|
|
GPR39
|
G protein-coupled receptor 39
|
|
GPR50
|
G protein-coupled receptor 50
|
|
GPRC6A
|
G protein-coupled receptor, class C, group 6, member A
|
|
GPSM1
|
G-protein signaling modulator 1
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX4
|
glutathione peroxidase 4
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRIA3
|
glutamate receptor, ionotropic, AMPA 3
|
|
GRIA4
|
glutamate receptor, ionotropic, AMPA 4
|
|
GRIK1
|
glutamate receptor, ionotropic, kainate 1
|
|
GRIK3
|
glutamate receptor, ionotropic, kainate 3
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GRM2
|
glutamate receptor, metabotropic 2
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
|
GRM5
|
glutamate receptor, metabotropic 5
|
|
GRN
|
granulin
|
|
GSDMA
|
gasdermin A
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSPT1
|
G1 to S phase transition 1
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTA2
|
glutathione S-transferase alpha 2
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GSTZ1
|
glutathione S-transferase zeta 1
|
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa
|
|
GUSB
|
glucuronidase, beta
|
|
GYPA
|
glycophorin A (MNS blood group)
|
|
GYS1
|
glycogen synthase 1 (muscle)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
GZMK
|
granzyme K (granzyme 3; tryptase II)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
H2AFX
|
H2A histone family, member X
|
|
H2AFZ
|
H2A histone family, member Z
|
|
HABP2
|
hyaluronan binding protein 2
|
|
HADHB
|
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HARS
|
histidyl-tRNA synthetase
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HBD
|
hemoglobin, delta
|
|
HBE1
|
hemoglobin, epsilon 1
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HBG1
|
hemoglobin, gamma A
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HCRTR1
|
hypocretin (orexin) receptor 1
|
|
HDAC1
|
histone deacetylase 1
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HDHD1
|
haloacid dehalogenase-like hydrolase domain containing 1
|
|
HEBP1
|
heme binding protein 1
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HESX1
|
HESX homeobox 1
|
|
HEXB
|
hexosaminidase B (beta polypeptide)
|
|
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1
|
|
HEY2
|
hes-related family bHLH transcription factor with YRPW motif 2
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HGFAC
|
HGF activator
|
|
HGS
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HIST2H2AC
|
histone cluster 2, H2ac
|
|
HIST2H3C
|
histone cluster 2, H3c
|
|
HIST2H4A
|
histone cluster 2, H4a
|
|
HIST3H2BB
|
histone cluster 3, H2bb
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMBS
|
hydroxymethylbilane synthase
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMGB2
|
high mobility group box 2
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HNRNPF
|
heterogeneous nuclear ribonucleoprotein F
|
|
HNRNPM
|
heterogeneous nuclear ribonucleoprotein M
|
|
HOXA13
|
homeobox A13
|
|
HOXB13
|
homeobox B13
|
|
HOXB4
|
homeobox B4
|
|
HP
|
haptoglobin
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HPSE
|
heparanase
|
|
HR
|
hair growth associated
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH4
|
histamine receptor H4
|
|
HS3ST2
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 2
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B10
|
hydroxysteroid (17-beta) dehydrogenase 10
|
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB8
|
heat shock 22kDa protein 8
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTN1
|
histatin 1
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2A-AS1
|
HTR2A antisense RNA 1
|
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
|
|
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
|
|
HTR6
|
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HTT
|
huntingtin
|
|
HUWE1
|
HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase
|
|
HYPK
|
huntingtin interacting protein K
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM4
|
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1
|
|
IFITM5
|
interferon induced transmembrane protein 5
|
|
IFN1@
|
interferon, type 1, cluster
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL3
|
interferon, lambda 3
|
|
IFT140
|
intraflagellar transport 140
|
|
IGBP1
|
immunoglobulin (CD79A) binding protein 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGHA1
|
immunoglobulin heavy constant alpha 1
|
|
IGHV3-21
|
immunoglobulin heavy variable 3-21
|
|
IGL
|
immunoglobulin lambda locus
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL17C
|
interleukin 17C
|
|
IL17F
|
interleukin 17F
|
|
IL17RB
|
interleukin 17 receptor B
|
|
IL18
|
interleukin 18
|
|
IL18BP
|
interleukin 18 binding protein
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL22
|
interleukin 22
|
|
IL23R
|
interleukin 23 receptor
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL31
|
interleukin 31
|
|
IL32
|
interleukin 32
|
|
IL33
|
interleukin 33
|
|
IL33R
|
interleukin 33 receptor
|
|
IL36A
|
interleukin 36, alpha
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL7R
|
interleukin 7 receptor
|
|
ILK
|
integrin-linked kinase
|
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2
|
|
ING1
|
inhibitor of growth family, member 1
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
INHBB
|
inhibin, beta B
|
|
INS
|
insulin
|
|
INSC
|
inscuteable homolog (Drosophila)
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
INSR
|
insulin receptor
|
|
INTS9
|
integrator complex subunit 9
|
|
IPO5
|
importin 5
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRF7
|
interferon regulatory factor 7
|
|
ISYNA1
|
inositol-3-phosphate synthase 1
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITIH3
|
inter-alpha-trypsin inhibitor heavy chain 3
|
|
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
IVL
|
involucrin
|
|
JAG1
|
jagged 1
|
|
JAK2
|
Janus kinase 2
|
|
JAM3
|
junctional adhesion molecule 3
|
|
JAZF1
|
JAZF zinc finger 1
|
|
JUN
|
jun proto-oncogene
|
|
JUND
|
jun D proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KARS
|
lysyl-tRNA synthetase
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNC1
|
potassium channel, voltage gated Shaw related subfamily C, member 1
|
|
KCNC2
|
potassium channel, voltage gated Shaw related subfamily C, member 2
|
|
KCNC4
|
potassium channel, voltage gated Shaw related subfamily C, member 4
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNE4
|
potassium channel, voltage gated subfamily E regulatory beta subunit 4
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNH5
|
potassium channel, voltage gated eag related subfamily H, member 5
|
|
KCNH6
|
potassium channel, voltage gated eag related subfamily H, member 6
|
|
KCNH7
|
potassium channel, voltage gated eag related subfamily H, member 7
|
|
KCNIP3
|
Kv channel interacting protein 3, calsenilin
|
|
KCNJ1
|
potassium channel, inwardly rectifying subfamily J, member 1
|
|
KCNJ10
|
potassium channel, inwardly rectifying subfamily J, member 10
|
|
KCNJ18
|
potassium channel, inwardly rectifying subfamily J, member 18
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNK16
|
potassium channel, two pore domain subfamily K, member 16
|
|
KCNK9
|
potassium channel, two pore domain subfamily K, member 9
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNN2
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
|
KCNQ4
|
potassium channel, voltage gated KQT-like subfamily Q, member 4
|
|
KCNRG
|
potassium channel regulator
|
|
KCNU1
|
potassium channel, subfamily U, member 1
|
|
KCNV2
|
potassium channel, voltage gated modifier subfamily V, member 2
|
|
KCTD12
|
potassium channel tetramerization domain containing 12
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM2A
|
lysine (K)-specific demethylase 2A
|
|
KDM5C
|
lysine (K)-specific demethylase 5C
|
|
KDM6B
|
lysine (K)-specific demethylase 6B
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA0196
|
KIAA0196
|
|
KIAA1549
|
KIAA1549
|
|
KIF21A
|
kinesin family member 21A
|
|
KIF5B
|
kinesin family member 5B
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DL5A
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR2DS3
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3
|
|
KIR2DS4
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
|
|
KIR2DS5
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KISS1R
|
KISS1 receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KL
|
klotho
|
|
KLC1
|
kinesin light chain 1
|
|
KLF14
|
Kruppel-like factor 14
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLHL7
|
kelch-like family member 7
|
|
KLK14
|
kallikrein-related peptidase 14
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK6
|
kallikrein-related peptidase 6
|
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMO
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
KNG1
|
kininogen 1
|
|
KPNA3
|
karyopherin alpha 3 (importin alpha 4)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
KRT1
|
keratin 1, type II
|
|
KRT10
|
keratin 10, type I
|
|
KRT14
|
keratin 14, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT7
|
keratin 7, type II
|
|
KRT8
|
keratin 8, type II
|
|
KRTCAP2
|
keratinocyte associated protein 2
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
L2HGDH
|
L-2-hydroxyglutarate dehydrogenase
|
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1
|
|
LAMB3
|
laminin, beta 3
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LAMP2
|
lysosomal-associated membrane protein 2
|
|
LAMP3
|
lysosomal-associated membrane protein 3
|
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
|
LAT
|
linker for activation of T cells
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LCA5
|
Leber congenital amaurosis 5
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LCE6A
|
late cornified envelope 6A
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LCT
|
lactase
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEMD3
|
LEM domain containing 3
|
|
LEP
|
leptin
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LEPR
|
leptin receptor
|
|
LETM1
|
leucine zipper-EF-hand containing transmembrane protein 1
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS2
|
lectin, galactoside-binding, soluble, 2
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LHB
|
luteinizing hormone beta polypeptide
|
|
LHFP
|
lipoma HMGIC fusion partner
|
|
LHFPL1
|
lipoma HMGIC fusion partner-like 1
|
|
LHFPL2
|
lipoma HMGIC fusion partner-like 2
|
|
LHFPL3
|
lipoma HMGIC fusion partner-like 3
|
|
LHFPL4
|
lipoma HMGIC fusion partner-like 4
|
|
LHFPL5
|
lipoma HMGIC fusion partner-like 5
|
|
LHX3
|
LIM homeobox 3
|
|
LHX4
|
LIM homeobox 4
|
|
LIF
|
leukemia inhibitory factor
|
|
LIFR
|
leukemia inhibitory factor receptor alpha
|
|
LINGO1
|
leucine rich repeat and Ig domain containing 1
|
|
LIPC
|
lipase, hepatic
|
|
LIPE
|
lipase, hormone-sensitive
|
|
LIPG
|
lipase, endothelial
|
|
LIPH
|
lipase, member H
|
|
LIPI
|
lipase, member I
|
|
LMAN1
|
lectin, mannose-binding, 1
|
|
LMNA
|
lamin A/C
|
|
LMNB1
|
lamin B1
|
|
LMO1
|
LIM domain only 1 (rhombotin 1)
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LMO3
|
LIM domain only 3 (rhombotin-like 2)
|
|
LMX1B
|
LIM homeobox transcription factor 1, beta
|
|
LNPEP
|
leucyl/cystinyl aminopeptidase
|
|
LNX1
|
ligand of numb-protein X 1, E3 ubiquitin protein ligase
|
|
LOR
|
loricrin
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LPAR6
|
lysophosphatidic acid receptor 6
|
|
LPIN1
|
lipin 1
|
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
|
LRIG2
|
leucine-rich repeats and immunoglobulin-like domains 2
|
|
LRP4
|
low density lipoprotein receptor-related protein 4
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRRC32
|
leucine rich repeat containing 32
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
LTBP2
|
latent transforming growth factor beta binding protein 2
|
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3)
|
|
LTF
|
lactotransferrin
|
|
LUM
|
lumican
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
LYST
|
lysosomal trafficking regulator
|
|
LYZ
|
lysozyme
|
|
MAATS1
|
MYCBP-associated, testis expressed 1
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAD2L1BP
|
MAD2L1 binding protein
|
|
MAGEA1
|
melanoma antigen family A1
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAGEA4
|
melanoma antigen family A4
|
|
MAGEC1
|
melanoma antigen family C1
|
|
MAGEC2
|
melanoma antigen family C2
|
|
MAL
|
mal, T-cell differentiation protein
|
|
MALT1
|
MALT1 paracaspase
|
|
MAML1
|
mastermind-like 1 (Drosophila)
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MANBA
|
mannosidase, beta A, lysosomal
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK8IP1
|
mitogen-activated protein kinase 8 interacting protein 1
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MARS
|
methionyl-tRNA synthetase
|
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)
|
|
MASP2
|
mannan-binding lectin serine peptidase 2
|
|
MASTL
|
microtubule associated serine/threonine kinase-like
|
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor)
|
|
MBL1P
|
mannose-binding lectin (protein A) 1, pseudogene
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MBNL1
|
muscleblind-like splicing regulator 1
|
|
MBOAT4
|
membrane bound O-acyltransferase domain containing 4
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCFD2
|
multiple coagulation factor deficiency 2
|
|
MCM10
|
minichromosome maintenance complex component 10
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MCM3
|
minichromosome maintenance complex component 3
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MCOLN1
|
mucolipin 1
|
|
MCTP2
|
multiple C2 domains, transmembrane 2
|
|
MCTS1
|
malignant T cell amplified sequence 1
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MDH1
|
malate dehydrogenase 1, NAD (soluble)
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
ME2
|
malic enzyme 2, NAD(+)-dependent, mitochondrial
|
|
MEAF6
|
MYST/Esa1-associated factor 6
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED12
|
mediator complex subunit 12
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEFV
|
Mediterranean fever
|
|
MEG3
|
maternally expressed 3 (non-protein coding)
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MEP1A
|
meprin A, alpha (PABA peptide hydrolase)
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFAP2
|
microfibrillar-associated protein 2
|
|
MFN2
|
mitofusin 2
|
|
MFRP
|
membrane frizzled-related protein
|
|
MGARP
|
mitochondria-localized glutamic acid-rich protein
|
|
MGLL
|
monoglyceride lipase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIA
|
melanoma inhibitory activity
|
|
MIA3
|
melanoma inhibitory activity family, member 3
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR107
|
microRNA 107
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR127
|
microRNA 127
|
|
MIR134
|
microRNA 134
|
|
MIR146A
|
microRNA 146a
|
|
MIR149
|
microRNA 149
|
|
MIR153-1
|
microRNA 153-1
|
|
MIR155
|
microRNA 155
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR181A1HG
|
MIR181A1 host gene
|
|
MIR181B1
|
microRNA 181b-1
|
|
MIR182
|
microRNA 182
|
|
MIR195
|
microRNA 195
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR196B
|
microRNA 196b
|
|
MIR19A
|
microRNA 19a
|
|
MIR203A
|
microRNA 203a
|
|
MIR204
|
microRNA 204
|
|
MIR205
|
microRNA 205
|
|
MIR21
|
microRNA 21
|
|
MIR214
|
microRNA 214
|
|
MIR218-1
|
microRNA 218-1
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR223
|
microRNA 223
|
|
MIR31
|
microRNA 31
|
|
MIR34A
|
microRNA 34a
|
|
MIR34B
|
microRNA 34b
|
|
MIR34C
|
microRNA 34c
|
|
MIR362
|
microRNA 362
|
|
MIR367
|
microRNA 367
|
|
MIR375
|
microRNA 375
|
|
MIR378A
|
microRNA 378a
|
|
MIR494
|
microRNA 494
|
|
MIR499A
|
microRNA 499a
|
|
MIR663A
|
microRNA 663a
|
|
MIR93
|
microRNA 93
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLF1
|
myeloid leukemia factor 1
|
|
MLH1
|
mutL homolog 1
|
|
MLH3
|
mutL homolog 3
|
|
MMD2
|
monocyte to macrophage differentiation-associated 2
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP25
|
matrix metallopeptidase 25
|
|
MMP26
|
matrix metallopeptidase 26
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
|
MOK
|
MOK protein kinase
|
|
MORC3
|
MORC family CW-type zinc finger 3
|
|
MORF4L1
|
mortality factor 4 like 1
|
|
MPG
|
N-methylpurine-DNA glycosylase
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MPZ
|
myelin protein zero
|
|
MRC2
|
mannose receptor, C type 2
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MRVI1
|
murine retrovirus integration site 1 homolog
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSLN
|
mesothelin
|
|
MSN
|
moesin
|
|
MSRA
|
methionine sulfoxide reductase A
|
|
MST1
|
macrophage stimulating 1
|
|
MSTN
|
myostatin
|
|
MT-ND4
|
NADH dehydrogenase, subunit 4 (complex I)
|
|
MT-ND5
|
NADH dehydrogenase, subunit 5 (complex I)
|
|
MT-ND6
|
NADH dehydrogenase, subunit 6 (complex I)
|
|
MT-TI
|
tRNA
|
|
MT-TM
|
tRNA
|
|
MT2A
|
metallothionein 2A
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTM1
|
myotubularin 1
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MTUS1
|
microtubule associated tumor suppressor 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MUC7
|
mucin 7, secreted
|
|
MUSK
|
muscle, skeletal, receptor tyrosine kinase
|
|
MUTYH
|
mutY homolog
|
|
MYBBP1A
|
MYB binding protein (P160) 1a
|
|
MYBPC1
|
myosin binding protein C, slow type
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCBP
|
MYC binding protein
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYO1B
|
myosin IB
|
|
MYO5A
|
myosin VA (heavy chain 12, myoxin)
|
|
MYO5B
|
myosin VB
|
|
MYO6
|
myosin VI
|
|
MYOD1
|
myogenic differentiation 1
|
|
MYRIP
|
myosin VIIA and Rab interacting protein
|
|
MYT1
|
myelin transcription factor 1
|
|
MYT1L
|
myelin transcription factor 1-like
|
|
N4BP2
|
NEDD4 binding protein 2
|
|
NAIP
|
NLR family, apoptosis inhibitory protein
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOG
|
Nanog homeobox
|
|
NANOS2
|
nanos homolog 2 (Drosophila)
|
|
NASP
|
nuclear autoantigenic sperm protein (histone-binding)
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCK1
|
NCK adaptor protein 1
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOA7
|
nuclear receptor coactivator 7
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NDE1
|
nudE neurodevelopment protein 1
|
|
NDN
|
necdin, melanoma antigen (MAGE) family member
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDRG2
|
NDRG family member 2
|
|
NDUFAF2
|
NADH dehydrogenase (ubiquinone) complex I, assembly factor 2
|
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NEK1
|
NIMA-related kinase 1
|
|
NES
|
nestin
|
|
NEU1
|
sialidase 1 (lysosomal sialidase)
|
|
NEU2
|
sialidase 2 (cytosolic sialidase)
|
|
NEU3
|
sialidase 3 (membrane sialidase)
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFASC
|
neurofascin
|
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFIA
|
nuclear factor I/A
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIL1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1
|
|
NGB
|
neuroglobin
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NHLH2
|
nescient helix loop helix 2
|
|
NHLRC1
|
NHL repeat containing E3 ubiquitin protein ligase 1
|
|
NIN
|
ninein (GSK3B interacting protein)
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLGN3
|
neuroligin 3
|
|
NLGN4X
|
neuroligin 4, X-linked
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NLRP7
|
NLR family, pyrin domain containing 7
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NNMT
|
nicotinamide N-methyltransferase
|
|
NOA1
|
nitric oxide associated 1
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOL3
|
nucleolar protein 3 (apoptosis repressor with CARD domain)
|
|
NONO
|
non-POU domain containing, octamer-binding
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS1AP
|
nitric oxide synthase 1 (neuronal) adaptor protein
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NOTCH4
|
notch 4
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NOXA1
|
NADPH oxidase activator 1
|
|
NPAS3
|
neuronal PAS domain protein 3
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPC1L1
|
NPC1-like 1
|
|
NPHP1
|
nephronophthisis 1 (juvenile)
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NPPC
|
natriuretic peptide C
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NPTN
|
neuroplastin
|
|
NPTX1
|
neuronal pentraxin I
|
|
NPTX2
|
neuronal pentraxin II
|
|
NPTXR
|
neuronal pentraxin receptor
|
|
NPY
|
neuropeptide Y
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRXN1
|
neurexin 1
|
|
NSFL1C
|
NSFL1 (p97) cofactor (p47)
|
|
NTF3
|
neurotrophin 3
|
|
NTF4
|
neurotrophin 4
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NTS
|
neurotensin
|
|
NTSR1
|
neurotensin receptor 1 (high affinity)
|
|
NUB1
|
negative regulator of ubiquitin-like proteins 1
|
|
NUCB2
|
nucleobindin 2
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
NUDT2
|
nudix (nucleoside diphosphate linked moiety X)-type motif 2
|
|
NUMBL
|
numb homolog (Drosophila)-like
|
|
NUP107
|
nucleoporin 107kDa
|
|
NUP133
|
nucleoporin 133kDa
|
|
NUP153
|
nucleoporin 153kDa
|
|
NUP214
|
nucleoporin 214kDa
|
|
NUP98
|
nucleoporin 98kDa
|
|
OCA2
|
oculocutaneous albinism II
|
|
OCLN
|
occludin
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OGFR
|
opioid growth factor receptor
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OIT3
|
oncoprotein induced transcript 3
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OPTN
|
optineurin
|
|
OR1D2
|
olfactory receptor, family 1, subfamily D, member 2
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORM1
|
orosomucoid 1
|
|
ORM2
|
orosomucoid 2
|
|
OSBPL2
|
oxysterol binding protein-like 2
|
|
OSBPL3
|
oxysterol binding protein-like 3
|
|
OSM
|
oncostatin M
|
|
OSMR
|
oncostatin M receptor
|
|
OSR1
|
odd-skipped related transciption factor 1
|
|
OTOG
|
otogelin
|
|
OTOGL
|
otogelin-like
|
|
OTX2
|
orthodenticle homeobox 2
|
|
OXTR
|
oxytocin receptor
|
|
P2RX3
|
purinergic receptor P2X, ligand gated ion channel, 3
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
P2RY11
|
purinergic receptor P2Y, G-protein coupled, 11
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
|
PABPN1
|
poly(A) binding protein, nuclear 1
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAH
|
phenylalanine hydroxylase
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PANX1
|
pannexin 1
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARP14
|
poly (ADP-ribose) polymerase family, member 14
|
|
PARP9
|
poly (ADP-ribose) polymerase family, member 9
|
|
PAX3
|
paired box 3
|
|
PAX6
|
paired box 6
|
|
PAX8
|
paired box 8
|
|
PAX9
|
paired box 9
|
|
PCDH11X
|
protocadherin 11 X-linked
|
|
PCDH11Y
|
protocadherin 11 Y-linked
|
|
PCID2
|
PCI domain containing 2
|
|
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble)
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCOLCE2
|
procollagen C-endopeptidase enhancer 2
|
|
PCSK1
|
proprotein convertase subtilisin/kexin type 1
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDCD6
|
programmed cell death 6
|
|
PDE10A
|
phosphodiesterase 10A
|
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDK4
|
pyruvate dehydrogenase kinase, isozyme 4
|
|
PDLIM1
|
PDZ and LIM domain 1
|
|
PDLIM5
|
PDZ and LIM domain 5
|
|
PDPN
|
podoplanin
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PDYN
|
prodynorphin
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PEMT
|
phosphatidylethanolamine N-methyltransferase
|
|
PER2
|
period circadian clock 2
|
|
PF4
|
platelet factor 4
|
|
PGC
|
progastricsin (pepsinogen C)
|
|
PGF
|
placental growth factor
|
|
PGM2
|
phosphoglucomutase 2
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked
|
|
PHF1
|
PHD finger protein 1
|
|
PHKA1
|
phosphorylase kinase, alpha 1 (muscle)
|
|
PHKA2
|
phosphorylase kinase, alpha 2 (liver)
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PHPT1
|
phosphohistidine phosphatase 1
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PI4K2A
|
phosphatidylinositol 4-kinase type 2 alpha
|
|
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIKFYVE
|
phosphoinositide kinase, FYVE finger containing
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PIP4K2A
|
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha
|
|
PITX1
|
paired-like homeodomain 1
|
|
PITX2
|
paired-like homeodomain 2
|
|
PITX3
|
paired-like homeodomain 3
|
|
PKN1
|
protein kinase N1
|
|
PKP2
|
plakophilin 2
|
|
PKP4
|
plakophilin 4
|
|
PLA2G10
|
phospholipase A2, group X
|
|
PLA2G2D
|
phospholipase A2, group IID
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLA2G5
|
phospholipase A2, group V
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLA2R1
|
phospholipase A2 receptor 1, 180kDa
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLD2
|
phospholipase D2
|
|
PLEKHA8
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8
|
|
PLG
|
plasminogen
|
|
PLIN1
|
perilipin 1
|
|
PLIN2
|
perilipin 2
|
|
PLIN3
|
perilipin 3
|
|
PLK1
|
polo-like kinase 1
|
|
PLN
|
phospholamban
|
|
PLOD3
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3
|
|
PLTP
|
phospholipid transfer protein
|
|
PML
|
promyelocytic leukemia
|
|
PMM2
|
phosphomannomutase 2
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNKD
|
paroxysmal nonkinesigenic dyskinesia
|
|
PNLIPRP2
|
pancreatic lipase-related protein 2
|
|
PNMT
|
phenylethanolamine N-methyltransferase
|
|
PNOC
|
prepronociceptin
|
|
PNP
|
purine nucleoside phosphorylase
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POLA1
|
polymerase (DNA directed), alpha 1, catalytic subunit
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLR2M
|
polymerase (RNA) II (DNA directed) polypeptide M
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
POU3F2
|
POU class 3 homeobox 2
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPFIA1
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPID
|
peptidylprolyl isomerase D
|
|
PPM1A
|
protein phosphatase, Mg2+/Mn2+ dependent, 1A
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP1R3A
|
protein phosphatase 1, regulatory subunit 3A
|
|
PPP1R3D
|
protein phosphatase 1, regulatory subunit 3D
|
|
PPP1R8
|
protein phosphatase 1, regulatory subunit 8
|
|
PPP1R9B
|
protein phosphatase 1, regulatory subunit 9B
|
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
|
PPP3CB
|
protein phosphatase 3, catalytic subunit, beta isozyme
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRCP
|
prolylcarboxypeptidase (angiotensinase C)
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRDX5
|
peroxiredoxin 5
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRG2
|
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
|
|
PRG4
|
proteoglycan 4
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCDBP
|
protein kinase C, delta binding protein
|
|
PRKCG
|
protein kinase C, gamma
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKRA
|
protein kinase, interferon-inducible double stranded RNA dependent activator
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PRM1
|
protamine 1
|
|
PRM2
|
protamine 2
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PRMT7
|
protein arginine methyltransferase 7
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROM1
|
prominin 1
|
|
PROP1
|
PROP paired-like homeobox 1
|
|
PROX1
|
prospero homeobox 1
|
|
PRPF31
|
pre-mRNA processing factor 31
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PRSS3P2
|
protease, serine, 3 pseudogene 2
|
|
PRSS8
|
protease, serine, 8
|
|
PSAP
|
prosaposin
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PSMA6
|
proteasome (prosome, macropain) subunit, alpha type, 6
|
|
PSMA7
|
proteasome (prosome, macropain) subunit, alpha type, 7
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PSMD4
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
|
|
PSMD7
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 7
|
|
PSME3
|
proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki)
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTBP2
|
polypyrimidine tract binding protein 2
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDR
|
prostaglandin D2 receptor (DP)
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK6
|
protein tyrosine kinase 6
|
|
PTN
|
pleiotrophin
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O
|
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1
|
|
PTRF
|
polymerase I and transcript release factor
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PTTG1IP
|
pituitary tumor-transforming 1 interacting protein
|
|
PVR
|
poliovirus receptor
|
|
PWAR5
|
Prader Willi/Angelman region RNA 5
|
|
PYY
|
peptide YY
|
|
QARS
|
glutaminyl-tRNA synthetase
|
|
QRFP
|
pyroglutamylated RFamide peptide
|
|
QSOX1
|
quiescin Q6 sulfhydryl oxidase 1
|
|
QSOX2
|
quiescin Q6 sulfhydryl oxidase 2
|
|
RAB23
|
RAB23, member RAS oncogene family
|
|
RAB25
|
RAB25, member RAS oncogene family
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAB27B
|
RAB27B, member RAS oncogene family
|
|
RAB40AL
|
RAB40A, member RAS oncogene family-like
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD51
|
RAD51 recombinase
|
|
RAD51AP2
|
RAD51 associated protein 2
|
|
RAD51C
|
RAD51 paralog C
|
|
RAE1
|
ribonucleic acid export 1
|
|
RAG1
|
recombination activating gene 1
|
|
RAG2
|
recombination activating gene 2
|
|
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1
|
|
RANBP2
|
RAN binding protein 2
|
|
RANGRF
|
RAN guanine nucleotide release factor
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARG
|
retinoic acid receptor, gamma
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1
|
|
RASGRF2
|
Ras protein-specific guanine nucleotide-releasing factor 2
|
|
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated)
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RB1
|
retinoblastoma 1
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
RBBP8
|
retinoblastoma binding protein 8
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
|
RDH5
|
retinol dehydrogenase 5 (11-cis/9-cis)
|
|
RECQL
|
RecQ helicase-like
|
|
RECQL5
|
RecQ protein-like 5
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELN
|
reelin
|
|
REN
|
renin
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
REXO2
|
RNA exonuclease 2
|
|
RFX1
|
regulatory factor X, 1 (influences HLA class II expression)
|
|
RFX2
|
regulatory factor X, 2 (influences HLA class II expression)
|
|
RGL2
|
ral guanine nucleotide dissociation stimulator-like 2
|
|
RGMA
|
repulsive guidance molecule family member a
|
|
RGS10
|
regulator of G-protein signaling 10
|
|
RGS18
|
regulator of G-protein signaling 18
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RHCE
|
Rh blood group, CcEe antigens
|
|
RHD
|
Rh blood group, D antigen
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
RHOF
|
ras homolog family member F (in filopodia)
|
|
RIMS1
|
regulating synaptic membrane exocytosis 1
|
|
RIMS2
|
regulating synaptic membrane exocytosis 2
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RIPK4
|
receptor-interacting serine-threonine kinase 4
|
|
RIT1
|
Ras-like without CAAX 1
|
|
RLN1
|
relaxin 1
|
|
RLN2
|
relaxin 2
|
|
RMND5A
|
required for meiotic nuclear division 5 homolog A (S. cerevisiae)
|
|
RNASE2
|
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RNF135
|
ring finger protein 135
|
|
RNF168
|
ring finger protein 168, E3 ubiquitin protein ligase
|
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
RP1L1
|
retinitis pigmentosa 1-like 1
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RPH3A
|
rabphilin 3A
|
|
RPL7
|
ribosomal protein L7
|
|
RPS19
|
ribosomal protein S19
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RSPO1
|
R-spondin 1
|
|
RTN1
|
reticulon 1
|
|
RTN4
|
reticulon 4
|
|
RTN4R
|
reticulon 4 receptor
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RUVBL1
|
RuvB-like AAA ATPase 1
|
|
RUVBL2
|
RuvB-like AAA ATPase 2
|
|
RXFP1
|
relaxin/insulin-like family peptide receptor 1
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
RYR3
|
ryanodine receptor 3
|
|
S100A10
|
S100 calcium binding protein A10
|
|
S100A16
|
S100 calcium binding protein A16
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A6
|
S100 calcium binding protein A6
|
|
S100A7
|
S100 calcium binding protein A7
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
|
SAA1
|
serum amyloid A1
|
|
SACS
|
sacsin molecular chaperone
|
|
SAG
|
S-antigen; retina and pineal gland (arrestin)
|
|
SAMD1
|
sterile alpha motif domain containing 1
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCG2
|
secretogranin II
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCGB1D2
|
secretoglobin, family 1D, member 2
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
|
SCN11A
|
sodium channel, voltage gated, type XI alpha subunit
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
|
SCTR
|
secretin receptor
|
|
SDC1
|
syndecan 1
|
|
SDC4
|
syndecan 4
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SEC61A1
|
Sec61 alpha 1 subunit (S. cerevisiae)
|
|
SECTM1
|
secreted and transmembrane 1
|
|
SELE
|
selectin E
|
|
SELENBP1
|
selenium binding protein 1
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SELPLG
|
selectin P ligand
|
|
SEPP1
|
selenoprotein P, plasma, 1
|
|
SEPT2
|
septin 2
|
|
SEPW1
|
selenoprotein W, 1
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA10
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SETBP1
|
SET binding protein 1
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFN
|
stratifin
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFTPB
|
surfactant protein B
|
|
SFTPC
|
surfactant protein C
|
|
SFTPD
|
surfactant protein D
|
|
SGCG
|
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SGTA
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha
|
|
SH2B2
|
SH2B adaptor protein 2
|
|
SH2D2A
|
SH2 domain containing 2A
|
|
SH2D3C
|
SH2 domain containing 3C
|
|
SH3BGRL
|
SH3 domain binding glutamate-rich protein like
|
|
SH3RF3
|
SH3 domain containing ring finger 3
|
|
SH3TC2
|
SH3 domain and tetratricopeptide repeats 2
|
|
SHANK2
|
SH3 and multiple ankyrin repeat domains 2
|
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SHMT2
|
serine hydroxymethyltransferase 2 (mitochondrial)
|
|
SHOX
|
short stature homeobox
|
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIK1
|
salt-inducible kinase 1
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIRT1
|
sirtuin 1
|
|
SIRT3
|
sirtuin 3
|
|
SIRT4
|
sirtuin 4
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
|
SLC10A1
|
solute carrier family 10 (sodium/bile acid cotransporter), member 1
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
|
SLC13A3
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3
|
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1
|
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter)
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC22A11
|
solute carrier family 22 (organic anion/urate transporter), member 11
|
|
SLC22A12
|
solute carrier family 22 (organic anion/urate transporter), member 12
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC23A1
|
solute carrier family 23 (ascorbic acid transporter), member 1
|
|
SLC25A1
|
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC30A1
|
solute carrier family 30 (zinc transporter), member 1
|
|
SLC30A3
|
solute carrier family 30 (zinc transporter), member 3
|
|
SLC30A4
|
solute carrier family 30 (zinc transporter), member 4
|
|
SLC30A5
|
solute carrier family 30 (zinc transporter), member 5
|
|
SLC30A6
|
solute carrier family 30 (zinc transporter), member 6
|
|
SLC30A7
|
solute carrier family 30 (zinc transporter), member 7
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC39A6
|
solute carrier family 39 (zinc transporter), member 6
|
|
SLC3A1
|
solute carrier family 3 (amino acid transporter heavy chain), member 1
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC41A1
|
solute carrier family 41 (magnesium transporter), member 1
|
|
SLC43A2
|
solute carrier family 43 (amino acid system L transporter), member 2
|
|
SLC45A2
|
solute carrier family 45, member 2
|
|
SLC46A1
|
solute carrier family 46 (folate transporter), member 1
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC4A11
|
solute carrier family 4, sodium borate transporter, member 11
|
|
SLC4A4
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 4
|
|
SLC4A7
|
solute carrier family 4, sodium bicarbonate cotransporter, member 7
|
|
SLC51A
|
solute carrier family 51, alpha subunit
|
|
SLC51B
|
solute carrier family 51, beta subunit
|
|
SLC5A2
|
solute carrier family 5 (sodium/glucose cotransporter), member 2
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC6A1
|
solute carrier family 6 (neurotransmitter transporter), member 1
|
|
SLC6A19
|
solute carrier family 6 (neutral amino acid transporter), member 19
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A5
|
solute carrier family 6 (neurotransmitter transporter), member 5
|
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8
|
|
SLC7A1
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1
|
|
SLC7A9
|
solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLCO1A2
|
solute carrier organic anion transporter family, member 1A2
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLCO2B1
|
solute carrier organic anion transporter family, member 2B1
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCAL1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SMOC1
|
SPARC related modular calcium binding 1
|
|
SMPX
|
small muscle protein, X-linked
|
|
SMURF1
|
SMAD specific E3 ubiquitin protein ligase 1
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SNIP1
|
Smad nuclear interacting protein 1
|
|
SNRNP35
|
small nuclear ribonucleoprotein 35kDa (U11/U12)
|
|
SNRPE
|
small nuclear ribonucleoprotein polypeptide E
|
|
SNTA1
|
syntrophin, alpha 1
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOCS7
|
suppressor of cytokine signaling 7
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
|
SOST
|
sclerostin
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX5
|
SRY (sex determining region Y)-box 5
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SPACA3
|
sperm acrosome associated 3
|
|
SPAG9
|
sperm associated antigen 9
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPATC1
|
spermatogenesis and centriole associated 1
|
|
SPEG
|
SPEG complex locus
|
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome)
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1
|
|
SPN
|
sialophorin
|
|
SPOCK1
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1
|
|
SPOP
|
speckle-type POZ protein
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPR
|
sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)
|
|
SPRED2
|
sprouty-related, EVH1 domain containing 2
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SPTLC1
|
serine palmitoyltransferase, long chain base subunit 1
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SRPK1
|
SRSF protein kinase 1
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
SRXN1
|
sulfiredoxin 1
|
|
SRY
|
sex determining region Y
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
|
SST
|
somatostatin
|
|
SSTR1
|
somatostatin receptor 1
|
|
SSTR2
|
somatostatin receptor 2
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAU1
|
staufen double-stranded RNA binding protein 1
|
|
STC1
|
stanniocalcin 1
|
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STK3
|
serine/threonine kinase 3
|
|
STK39
|
serine threonine kinase 39
|
|
STMN1
|
stathmin 1
|
|
STOML2
|
stomatin (EPB72)-like 2
|
|
STON2
|
stonin 2
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
SULT1A3
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3
|
|
SULT2A1
|
sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
|
|
SULT2B1
|
sulfotransferase family, cytosolic, 2B, member 1
|
|
SUMF1
|
sulfatase modifying factor 1
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUMO3
|
small ubiquitin-like modifier 3
|
|
SUMO4
|
small ubiquitin-like modifier 4
|
|
SUOX
|
sulfite oxidase
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
SYCP3
|
synaptonemal complex protein 3
|
|
SYK
|
spleen tyrosine kinase
|
|
SYNJ1
|
synaptojanin 1
|
|
SYP
|
synaptophysin
|
|
SYT2
|
synaptotagmin II
|
|
T
|
T, brachyury homolog (mouse)
|
|
TAC1
|
tachykinin, precursor 1
|
|
TAC3
|
tachykinin 3
|
|
TACR1
|
tachykinin receptor 1
|
|
TACR3
|
tachykinin receptor 3
|
|
TAF12
|
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa
|
|
TAF4
|
TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa
|
|
TALDO1
|
transaldolase 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAS1R3
|
taste receptor, type 1, member 3
|
|
TAS2R1
|
taste receptor, type 2, member 1
|
|
TAS2R16
|
taste receptor, type 2, member 16
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBP
|
TATA box binding protein
|
|
TBPL1
|
TBP-like 1
|
|
TBPL2
|
TATA box binding protein like 2
|
|
TBX21
|
T-box 21
|
|
TBX5
|
T-box 5
|
|
TCEA1
|
transcription elongation factor A (SII), 1
|
|
TCF3
|
transcription factor 3
|
|
TCF7
|
transcription factor 7 (T-cell specific, HMG-box)
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TCOF1
|
Treacher Collins-Franceschetti syndrome 1
|
|
TDRD7
|
tudor domain containing 7
|
|
TEAD4
|
TEA domain family member 4
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TF
|
transferrin
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFAP2B
|
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
|
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFEB
|
transcription factor EB
|
|
TFF1
|
trefoil factor 1
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TFR2
|
transferrin receptor 2
|
|
TFRC
|
transferrin receptor
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM2
|
transglutaminase 2
|
|
TGM3
|
transglutaminase 3
|
|
TGOLN2
|
trans-golgi network protein 2
|
|
TGS1
|
trimethylguanosine synthase 1
|
|
TH
|
tyrosine hydroxylase
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THBS2
|
thrombospondin 2
|
|
THNSL2
|
threonine synthase-like 2 (S. cerevisiae)
|
|
THRB
|
thyroid hormone receptor, beta
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIA1
|
TIA1 cytotoxic granule-associated RNA binding protein
|
|
TIAL1
|
TIA1 cytotoxic granule-associated RNA binding protein-like 1
|
|
TICAM2
|
toll-like receptor adaptor molecule 2
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TIMP4
|
TIMP metallopeptidase inhibitor 4
|
|
TJP1
|
tight junction protein 1
|
|
TJP2
|
tight junction protein 2
|
|
TK2
|
thymidine kinase 2, mitochondrial
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
|
TLN1
|
talin 1
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR6
|
toll-like receptor 6
|
|
TLR7
|
toll-like receptor 7
|
|
TLR9
|
toll-like receptor 9
|
|
TLX3
|
T-cell leukemia homeobox 3
|
|
TMEM47
|
transmembrane protein 47
|
|
TMEM8B
|
transmembrane protein 8B
|
|
TMOD3
|
tropomodulin 3 (ubiquitous)
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TMSB10
|
thymosin beta 10
|
|
TMSB4X
|
thymosin beta 4, X-linked
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10C
|
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNIP2
|
TNFAIP3 interacting protein 2
|
|
TNKS
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase
|
|
TNNC1
|
troponin C type 1 (slow)
|
|
TNNI2
|
troponin I type 2 (skeletal, fast)
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TNRC6A
|
trinucleotide repeat containing 6A
|
|
TNRC6C
|
trinucleotide repeat containing 6C
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOP2B
|
topoisomerase (DNA) II beta 180kDa
|
|
TOPORS
|
topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TOX3
|
TOX high mobility group box family member 3
|
|
TP53
|
tumor protein p53
|
|
TP53BP2
|
tumor protein p53 binding protein 2
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TPM2
|
tropomyosin 2 (beta)
|
|
TPM3
|
tropomyosin 3
|
|
TPM4
|
tropomyosin 4
|
|
TPO
|
thyroid peroxidase
|
|
TPT1
|
tumor protein, translationally-controlled 1
|
|
TRA
|
T cell receptor alpha locus
|
|
TRADD
|
TNFRSF1A-associated via death domain
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRAPPC2
|
trafficking protein particle complex 2
|
|
TRD
|
T cell receptor delta locus
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TREML4
|
triggering receptor expressed on myeloid cells-like 4
|
|
TRG
|
T cell receptor gamma locus
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRIM23
|
tripartite motif containing 23
|
|
TRIM33
|
tripartite motif containing 33
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRIM63
|
tripartite motif containing 63, E3 ubiquitin protein ligase
|
|
TRIO
|
trio Rho guanine nucleotide exchange factor
|
|
TRIP11
|
thyroid hormone receptor interactor 11
|
|
TRMU
|
tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPM1
|
transient receptor potential cation channel, subfamily M, member 1
|
|
TRPM3
|
transient receptor potential cation channel, subfamily M, member 3
|
|
TRPM6
|
transient receptor potential cation channel, subfamily M, member 6
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TSPO
|
translocator protein (18kDa)
|
|
TTK
|
TTK protein kinase
|
|
TTN
|
titin
|
|
TTR
|
transthyretin
|
|
TUBA1A
|
tubulin, alpha 1a
|
|
TUBB2B
|
tubulin, beta 2B class IIb
|
|
TUBG1
|
tubulin, gamma 1
|
|
TUBGCP6
|
tubulin, gamma complex associated protein 6
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXN
|
thioredoxin
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
TYRP1
|
tyrosinase-related protein 1
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
|
UBB
|
ubiquitin B
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UBE4B
|
ubiquitination factor E4B
|
|
UCA1
|
urothelial cancer associated 1 (non-protein coding)
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCMA
|
upper zone of growth plate and cartilage matrix associated
|
|
UCN3
|
urocortin 3
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UGT1A
|
UDP glucuronosyltransferase 1 family, polypeptide A complex locus
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A4
|
UDP glucuronosyltransferase 1 family, polypeptide A4
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
UHRF2
|
ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase
|
|
UMOD
|
uromodulin
|
|
UNC13A
|
unc-13 homolog A (C. elegans)
|
|
UNC5C
|
unc-5 homolog C (C. elegans)
|
|
USH2A
|
Usher syndrome 2A (autosomal recessive, mild)
|
|
USP22
|
ubiquitin specific peptidase 22
|
|
USP24
|
ubiquitin specific peptidase 24
|
|
USP26
|
ubiquitin specific peptidase 26
|
|
USP36
|
ubiquitin specific peptidase 36
|
|
USP40
|
ubiquitin specific peptidase 40
|
|
USP6
|
ubiquitin specific peptidase 6
|
|
UTRN
|
utrophin
|
|
UTS2R
|
urotensin 2 receptor
|
|
UVRAG
|
UV radiation resistance associated
|
|
VAMP3
|
vesicle-associated membrane protein 3
|
|
VAMP7
|
vesicle-associated membrane protein 7
|
|
VAMP8
|
vesicle-associated membrane protein 8
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VAV2
|
vav 2 guanine nucleotide exchange factor
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCP
|
valosin containing protein
|
|
VDAC3
|
voltage-dependent anion channel 3
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFB
|
vascular endothelial growth factor B
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VGF
|
VGF nerve growth factor inducible
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VIP
|
vasoactive intestinal peptide
|
|
VIPAS39
|
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
VPREB3
|
pre-B lymphocyte 3
|
|
VPS33B
|
vacuolar protein sorting 33 homolog B (yeast)
|
|
VTI1A
|
vesicle transport through interaction with t-SNAREs 1A
|
|
VTN
|
vitronectin
|
|
VTRNA2-1
|
vault RNA 2-1
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WNT2
|
wingless-type MMTV integration site family member 2
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
|
WNT8B
|
wingless-type MMTV integration site family, member 8B
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
XBP1
|
X-box binding protein 1
|
|
XDH
|
xanthine dehydrogenase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XPO1
|
exportin 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC2
|
X-ray repair complementing defective repair in Chinese hamster cells 2
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
XRN2
|
5'-3' exoribonuclease 2
|
|
YBX1
|
Y box binding protein 1
|
|
YWHAE
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
|
YY1
|
YY1 transcription factor
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZBTB34
|
zinc finger and BTB domain containing 34
|
|
ZC3H12A
|
zinc finger CCCH-type containing 12A
|
|
ZC3H14
|
zinc finger CCCH-type containing 14
|
|
ZDHHC8
|
zinc finger, DHHC-type containing 8
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZNF224
|
zinc finger protein 224
|
|
ZNF510
|
zinc finger protein 510
|
|
ZNF782
|
zinc finger protein 782
|
|
ZNF804A
|
zinc finger protein 804A
|
|
ZP1
|
zona pellucida glycoprotein 1 (sperm receptor)
|
|
ZP2
|
zona pellucida glycoprotein 2 (sperm receptor)
|
|
ZP3
|
zona pellucida glycoprotein 3 (sperm receptor)
|
